Literature DB >> 3029335

Demyelinating neuropathy associated with hepatitis B virus infection. Detection of immune complexes composed of hepatitis B virus surface antigen.

N Tsukada, C S Koh, A Inoue, N Yanagisawa.   

Abstract

We observed 4 patients with the Guillain-Barré syndrome (GBS) type of polyneuropathy and one patient with chronic relapsing polyneuropathy associated with hepatitis B virus infection, and examined the sera, cerebrospinal fluid (CSF) and sural nerve specimens from the patients in search of the pathogenetic factors involved. It was demonstrated that hepatitis B surface antigen(HBsAg)-immune complexes were significantly increased in both the sera and the CSF of the 4 patients with GBS. The serum levels of immune complexes were also closely related to the clinical status of these patients. In all patients, HBsAg-positive labelling of immunofluorescence was found around the endoneural small blood vessels and in the endoneurium. Electron-dense deposits, suggestive of immune complexes composed of hepatitis B virus, were demonstrated in the endoneurium of the patient with chronic relapsing polyneuropathy. These results suggest that HBsAg immune complexes may be of importance in the etiology of GBS or chronic relapsing polyneuropathy associated with hepatitis B virus infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029335     DOI: 10.1016/0022-510x(87)90123-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  A case of relapsing Guillain-Barré syndrome associated with exacerbation of chronic hepatitis B virus hepatitis.

Authors:  Elisabeth Chroni; Constantinos Thomopoulos; Spiridon Papapetropoulos; Christos Paschalis; Chrisoula Labropoulou Karatza
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

2.  A rare case of acute hepatitis B virus infection causing guillain-barré syndrome.

Authors:  Kidist K Yimam; Raphael B Merriman; R Todd Frederick
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-02

3.  Dramatic Improvement of Chronic Inflammatory Demyelinating Polyneuropathy Through Tenofovir Treatment in a Patient Infected with Hepatitis B Virus.

Authors:  Bora Aktas; Sebahat Basyigit; Barış Yılmaz; Tülin Aktürk; Yasar Nazligul
Journal:  J Neuroimmune Pharmacol       Date:  2015-04-08       Impact factor: 4.147

4.  Chronic polyradiculoneuropathy associated with human T-cell lymphotropic virus type I infection.

Authors:  K Arakawa; H Umezaki; S Noda; H Itoh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-04       Impact factor: 10.154

5.  Multiplex neuritis in a patient with autoimmune hepatitis: a case report.

Authors:  S Luth; F Birklein; C Schramm; J Herkel; E Hennes; W Muller-Forell; P R Galle; A W Lohse
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

6.  Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection.

Authors:  S Cronin; R McNicholas; E Kavanagh; V Reid; K O'Rourke
Journal:  Ir J Med Sci       Date:  2010-11-10       Impact factor: 1.568

7.  Guillain-Barré syndrome: rare extra-intestinal manifestation of hepatitis B.

Authors:  Amey Dilip Sonavane; Sanjiv Saigal; Abhishek Kathuria; Narendra S Choudhary; Neeraj Saraf
Journal:  Clin J Gastroenterol       Date:  2018-03-14

8.  Mononeuropathy multiplex in a patient with chronic active hepatitis B.

Authors:  Tai Seung Nam; Seung Han Lee; Man Seok Park; Kang Ho Choi; Joon Tae Kim; Seong Min Choi; Byeong Chae Kim; Myeong Kyu Kim; Ki Hyun Cho
Journal:  J Clin Neurol       Date:  2010-09-30       Impact factor: 3.077

Review 9.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

10.  Contribution of quantitative viral markers to document hepatitis B virus compartmentalization in cerebrospinal fluid during hepatitis B with neuropathies.

Authors:  Charlotte Pronier; Dominique Guyader; Caroline Jézequel; Pierre Tattevin; Vincent Thibault
Journal:  J Neurovirol       Date:  2018-08-10       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.